Equels Thomas K bought AIM
September 15, 2026 · Form 4 insider transaction
Equels Thomas K bought 22,000 shares of AIM ImmunoTech Inc. at $0.22 per share, a transaction worth $4.9K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
22,000
Price
$0.22
Total value
$4.9K
InsiderEquels Thomas K
Role—
CompanyAIM ImmunoTech Inc. (AIM)
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateSeptember 15, 2026
Filing dateSeptember 16, 2026
Shares owned after91,822
OwnershipDirect
10b5-1 planNo
AmendedNo